Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: Impact on the epidemiology of chronic kidney disease

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Delanaye, Pierre ^a   Cavalier, Etienne ^a   Moranne, Olivier ^b   Lutteri, Laurence ^a   Krzesinski, Jean Marie ^a   Bruyère, Olivier ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Chronic kidney disease; Creatinine; Cystatin C; Glomerular filtration rate

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; BELGIUM; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; POPULATION RESEARCH; PREVALENCE;

AGED; AGED, 80 AND OVER; BELGIUM; BIOLOGICAL MARKERS; COHORT STUDIES; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84874768238     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-57     Document Type: Article

References (52)

1. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697
2. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. McCullough K, Sharma P, Ali T, Khan I, Smith WC, Macleod A, Nephrol Dial Transplant 2012 27 1812 1821 10.1093/ndt/gfr547 21965592
3. Age and association of kidney measures with mortality and End-stage renal disease. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, JAMA 2012 308 2349 2360 10.1001/jama.2012.16817 23111824
4. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Lancet 2012 380 1649 1661 10.1016/S0140-6736(12)61272-0 23013600
5. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van d V, Astor BC, Woodward M, Levey AS, de Jong PE, Lancet 2010 375 2073 2081 20483451
6. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Hallan SI, Vikse BE, Curr Opin Nephrol Hypertens 2008 17 286 291 10.1097/MNH.0b013e3282f8b177 18408480
7. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive services task force and for an American college of physicians clinical practice guideline. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Ann Intern Med 2012 156 570 581 10.7326/0003-4819-156-8-201204170-00008 22508734
8. Screening for chronic kidney disease: U.S. Preventive services task force recommendation statement. Moyer VA, Ann Intern Med 2012 157 567 570 10.7326/0003-4819-157-8-201210160-00533 22928170
9. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Levey AS, de Jong PE, Coresh J, El NM, Astor BC, Matsushita K, Kidney Int 2011 80 17 28 10.1038/ki.2010.483 21150873
10. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Ann Intern Med 2006 145 247 254 10.7326/0003-4819-145-4-200608150-00004 16908915
11. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Ann Intern Med 2009 150 604 612 10.7326/0003-4819-150-9-200905050-00006 19414839
12. Formula-based estimates of the GFR: equations variable and uncertain. Delanaye P, Cohen EP, Nephron Clin Pract 2008 110 48 c53 10.1159/000151436 18708727
13. Cystatin C. Newman DJ, Ann Clin Biochem 2002 39 89 104 10.1258/0004563021901847 11928770
14. Cystatin C-properties and use as diagnostic marker. Grubb AO, Adv Clin Chem 2000 35 63 99 11040958
15. Cystatin C: point d'étape et perspectives. Seronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP, Ann Biol Clin (Paris) 2008 66 301 323
16. Cystatin C: current position and future prospects. Seronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP, Clin Chem Lab Med 2008 46 1664 1686 18973461
17. Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Delanaye P, Pieroni L, Abshoff C, Lutteri L, Chapelle JP, Krzesinski JM, Clin Chim Acta 2008 398 118 124 10.1016/j.cca.2008. 09.001 18805407
18. Calibration of the siemens cystatin C immunoassay has changed over time. Larsson A, Hansson LO, Flodin M, Katz R, Shlipak MG, Clin Chem 2011 57 777 778 10.1373/clinchem.2010.159848 21364028
19. The impact of interlaboratory differences in cystatin C assay measurement on glomerular filtration rate estimation. White CA, Rule AD, Collier CP, Akbari A, Lieske JC, Lepage N, Clin J Am Soc Nephrol 2011 6 2150 2156 10.2215/CJN.00130111 21799146
20. Importance of cystatin C assay standardization. Voskoboev NV, Larson TS, Rule AD, Lieske JC, Clin Chem 2011 57 1209 1211 10.1373/clinchem.2011.164798 21666068
21. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Delanaye P, Cavalier E, Saint-Remy A, Lutteri L, Krzesinski JM, Scand J Clin Lab Invest 2009 69 344 349 10.1080/00365510802609856 19051098
22. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I, Clin Chem Lab Med 2010 48 1619 1621 21034257
23. Estimating glomerular filtration rate from serum creatinine and cystatin C. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, N Engl J Med 2012 367 20 29 10.1056/NEJMoa1114248 22762315
24. Accuracy of the MDRD (modification of diet in renal disease) study and CKD-EPI (CKD epidemiology collaboration) equations for estimation of GFR in the elderly. Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, Delaney MP, AJKD 2013 61 57 66 10.1053/j.ajkd.2012.06.016 22889713
25. The measurement of observer agreement for categorical data. Landis JR, Koch GG, Biometrics 1977 33 159 174 10.2307/2529310 843571
26. Statistical methods for assessing agreement between two methods of clinical measurement. Bland JM, Altman DG, Lancet 1986 1 307 310 2868172
27. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, J Am Soc Nephrol 2006 17 2275 2284 10.1681/ASN.2005121273 16790511
28. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Hallan S, Asberg A, Lindberg M, Johnsen H, Am J Kidney Dis 2004 44 84 93 10.1053/j.ajkd.2004.03.027 15211442
29. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. Coresh J, Eknoyan G, Levey AS, J Am Soc Nephrol 2002 13 2811 2812 10.1097/01.ASN.0000037420.89149.C9 12397055
30. Predictive performance of the modification of diet in renal disease and cockcroft-gault equations for estimating renal function. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P, J Am Soc Nephrol 2005 16 763 773 10.1681/ASN.2004070549 15659562
31. An epidemic of chronic kidney disease: fact or fiction? Glassock RJ, Winearls C, Nephrol Dial Transplant 2008 23 1117 1121 18359870
32. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? Delanaye P, Cavalier E, Mariat C, Maillard N, Krzesinski JM, BMC Nephrol 2010 11 8 10.1186/1471-2369-11-8 20515483
33. Time to change the glomerular filtration rate estimating formula in primary care? Korhonen PE, Kautiainen H, Jarvenpaa S, Kivela SL, Eur J Intern Med 2012 23 355 357 10.1016/j.ejim.2012.01.001 22560385
34. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. O'Callaghan CA, Shine B, Lasserson DS, BMJ Open 2011 1 000308 10.1136/bmjopen-2011-000308 22184586
35. Implications of the CKD-EPI GFR estimation equation in clinical practice. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Clin J Am Soc Nephrol 2011 6 497 504 10.2215/CJN.04240510 21115622
36. Epidemiology and prognostic significance of chronic kidney disease in the elderly-the three-city prospective cohort study. Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, Tzourio C, Nephrol Dial Transplant 2011 26 3286 3295 10.1093/ndt/gfr323 21677301
37. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a caucasian population. van den Brand JA, van Boekel GA, Willems HL, Kiemeney LA, den HM, Wetzels JF, Nephrol Dial Transplant 2011 26 3176 3181 10.1093/ndt/gfr003 21325352
38. Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age. Carter JL, Stevens PE, Irving JE, Lamb EJ, QJM 2011 104 839 847 10.1093/qjmed/hcr077 21652537
39. GFR estimation using the cockcroft-gault, MDRD study, and CKD-EPI equations in the elderly. Flamant M, Haymann JP, Vidal-Petiot E, Letavernier E, Clerici C, Boffa JJ, Am J Kidney Dis 2012 60 847 849 10.1053/j.ajkd.2012.08.001 22938847
40. GFR estimation using standardized cystatin C in kidney transplant recipients. Masson I, Maillard N, Tack I, Thibaudin L, Dubourg L, Delanaye P, AJKD 2013 61 279 284 10.1053/j.ajkd.2012.09.010 23141866
41. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, JAMA 2011 305 1545 1552 10.1001/jama.2011.468 21482744
42. Cystatin C and the risk of death and cardiovascular events among elderly persons. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, N Engl J Med 2005 352 2049 2060 10.1056/NEJMoa043161 15901858
43. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, JAIDS 2012 61 302 309 10.1097/QAI. 0b013e31826a6c4f 22842844
44. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 461 470 10.7326/0003-4819-130-6-199903160-00002 10075613
45. Two novel equations to estimate kidney function in persons aged 70 years or older. Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, Ann Intern Med 2012 157 471 481 10.7326/0003-4819-157-7-201210020-00003 23027318
46. Normal reference values for glomerular filtration rate: what do we really know? Delanaye P, Schaeffner E, Ebert N, Cavalier E, Mariat C, Krzesinski JM, Nephrol Dial Transplant 2012 27 2664 2672 10.1093/ndt/gfs265 22802582
47. Factors other than glomerular filtration rate affect serum cystatin C levels. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Kidney Int 2009 75 652 660 10.1038/ki.2008.638 19119287
48. Prevalence of chronic renal failure in adults in Delhi, India. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM, Nephrol Dial Transplant 2005 20 1638 1642 10.1093/ndt/gfh855 15855202
49. Unreferred chronic kidney disease: a longitudinal study. John R, Webb M, Young A, Stevens PE, Am J Kidney Dis 2004 43 825 835 10.1053/j.ajkd.2003.12.046 15112173
50. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Nissenson AR, Pereira BJ, Collins AJ, Steinberg EP, Am J Kidney Dis 2001 37 1177 1183 10.1053/ajkd.2001.24520 11382686
51. The MDRD equation underestimates the prevalence of CKD among blacks and overestimates the prevalence of CKD among whites compared to the CKD-EPI equation: a retrospective cohort study. Arora P, Rajagopalan S, Patel N, Nainani N, Venuto RC, Lohr JW, BMC Nephrol 2012 13 4 10.1186/1471-2369-13-4 22264268
52. Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H, Nephron Clin Pract 2011 117 213 c224 10.1159/000320341 20805694